The type of factor VIII deficient plasma used influences the performance of the Nijmegen modification of the Bethesda assay for factor VIII inhibitors - Verbruggen,B.; Giles,A.; Samis,J.; Verbeek,K.; Mensink,E.; Novákovà,I. (Thromb Haemost, 2001)